What dose and OAR constraints you use for boost with IMRT or SBRT when a patient with cancer of the cervix is not candidate for brachytherapy?  

Could you discuss how you decide between IMRT or SBRT boost for a patient who is not able to receive intracavitary or interstitial HDR or LDR brachytherapy?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Loyola University Chicago Stritch School of Medicine
Thanks to Bob for the answer. In 25 years of pract...
Radiation Oncologist at Affiliated Oncologists
Hear Hear.
Radiation Oncologist at Washington University School of Medicine
agree strongly
Sign in or Register to read more